File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Epidemiology and clinical features of Shewanella infection over an eight-year period
  • Basic View
  • Metadata View
  • XML View
TitleEpidemiology and clinical features of Shewanella infection over an eight-year period
 
AuthorsTo, KKW1
Wong, SSY1
Cheng, VCC1
Tang, BSF1
Li, IWS1
Chan, JFW1
Seto, WK2
Tse, H1
Yuen, KY1
 
Issue Date2010
 
PublisherInforma Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/00365548.asp
 
CitationScandinavian Journal Of Infectious Diseases, 2010, v. 42 n. 10, p. 757-762 [How to Cite?]
DOI: http://dx.doi.org/10.3109/00365548.2010.490562
 
AbstractShewanella is a rare human pathogen that can lead to fatal infections. However, clinical information about this bacterium remains scarce. In this study, we retrospectively reviewed all patients with laboratory isolates of Shewanella over an 8-y period to assess risk factors, clinical manifestations and outcome. Twenty-nine patients were identified. Shewanella was most commonly isolated from intra-abdominal specimens (48.2%), followed by skin and soft tissue specimens (27.6%), blood (13.8%) and sputum (10.3%). Malignancy, hepatobiliary disease and diabetes mellitus were common underlying diseases. The overall 30-day mortality rate was 20.6%. Shewanella was considered a definite causative pathogen in 7 patients, and a recurrent infection occurred in 2 patients. Colonization of the biliary tract was common. Among co-isolated pathogens, the enteric flora was most represented. All isolates were susceptible to ceftazidime and aminoglycosides, but 1 isolate was resistant to imipenem. In conclusion, Shewanella may become a colonizing bacterium, subsequently causing invasive diseases in patients with an underlying disease. © 2010 Informa Healthcare.
 
ISSN0036-5548
2012 Impact Factor: 1.706
2012 SCImago Journal Rankings: 0.647
 
DOIhttp://dx.doi.org/10.3109/00365548.2010.490562
 
ISI Accession Number IDWOS:000282987100006
 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorTo, KKW
 
dc.contributor.authorWong, SSY
 
dc.contributor.authorCheng, VCC
 
dc.contributor.authorTang, BSF
 
dc.contributor.authorLi, IWS
 
dc.contributor.authorChan, JFW
 
dc.contributor.authorSeto, WK
 
dc.contributor.authorTse, H
 
dc.contributor.authorYuen, KY
 
dc.date.accessioned2010-12-23T10:31:28Z
 
dc.date.available2010-12-23T10:31:28Z
 
dc.date.issued2010
 
dc.description.abstractShewanella is a rare human pathogen that can lead to fatal infections. However, clinical information about this bacterium remains scarce. In this study, we retrospectively reviewed all patients with laboratory isolates of Shewanella over an 8-y period to assess risk factors, clinical manifestations and outcome. Twenty-nine patients were identified. Shewanella was most commonly isolated from intra-abdominal specimens (48.2%), followed by skin and soft tissue specimens (27.6%), blood (13.8%) and sputum (10.3%). Malignancy, hepatobiliary disease and diabetes mellitus were common underlying diseases. The overall 30-day mortality rate was 20.6%. Shewanella was considered a definite causative pathogen in 7 patients, and a recurrent infection occurred in 2 patients. Colonization of the biliary tract was common. Among co-isolated pathogens, the enteric flora was most represented. All isolates were susceptible to ceftazidime and aminoglycosides, but 1 isolate was resistant to imipenem. In conclusion, Shewanella may become a colonizing bacterium, subsequently causing invasive diseases in patients with an underlying disease. © 2010 Informa Healthcare.
 
dc.description.natureLink_to_subscribed_fulltext
 
dc.identifier.citationScandinavian Journal Of Infectious Diseases, 2010, v. 42 n. 10, p. 757-762 [How to Cite?]
DOI: http://dx.doi.org/10.3109/00365548.2010.490562
 
dc.identifier.doihttp://dx.doi.org/10.3109/00365548.2010.490562
 
dc.identifier.epage762
 
dc.identifier.hkuros178247
 
dc.identifier.hkuros213670
 
dc.identifier.isiWOS:000282987100006
 
dc.identifier.issn0036-5548
2012 Impact Factor: 1.706
2012 SCImago Journal Rankings: 0.647
 
dc.identifier.issue10
 
dc.identifier.pmid20524786
 
dc.identifier.scopuseid_2-s2.0-77956819449
 
dc.identifier.spage757
 
dc.identifier.urihttp://hdl.handle.net/10722/130631
 
dc.identifier.volume42
 
dc.languageeng
 
dc.publisherInforma Healthcare. The Journal's web site is located at http://www.tandf.co.uk/journals/titles/00365548.asp
 
dc.publisher.placeUnited Kingdom
 
dc.relation.ispartofScandinavian Journal of Infectious Diseases
 
dc.relation.referencesReferences in Scopus
 
dc.subject.meshAdult
 
dc.subject.meshAged
 
dc.subject.meshAged, 80 and over
 
dc.subject.meshAnti-Bacterial Agents - pharmacology
 
dc.subject.meshFemale
 
dc.subject.meshGram-Positive Bacterial Infections - epidemiology - microbiology - mortality - physiopathology
 
dc.subject.meshHong Kong - epidemiology
 
dc.subject.meshHumans
 
dc.subject.meshMale
 
dc.subject.meshMicrobial Sensitivity Tests
 
dc.subject.meshMiddle Aged
 
dc.subject.meshPrognosis
 
dc.subject.meshRetrospective Studies
 
dc.subject.meshRisk Factors
 
dc.subject.meshShewanella - classification - drug effects - isolation & purification - pathogenicity
 
dc.titleEpidemiology and clinical features of Shewanella infection over an eight-year period
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>To, KKW</contributor.author>
<contributor.author>Wong, SSY</contributor.author>
<contributor.author>Cheng, VCC</contributor.author>
<contributor.author>Tang, BSF</contributor.author>
<contributor.author>Li, IWS</contributor.author>
<contributor.author>Chan, JFW</contributor.author>
<contributor.author>Seto, WK</contributor.author>
<contributor.author>Tse, H</contributor.author>
<contributor.author>Yuen, KY</contributor.author>
<date.accessioned>2010-12-23T10:31:28Z</date.accessioned>
<date.available>2010-12-23T10:31:28Z</date.available>
<date.issued>2010</date.issued>
<identifier.citation>Scandinavian Journal Of Infectious Diseases, 2010, v. 42 n. 10, p. 757-762</identifier.citation>
<identifier.issn>0036-5548</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/130631</identifier.uri>
<description.abstract>Shewanella is a rare human pathogen that can lead to fatal infections. However, clinical information about this bacterium remains scarce. In this study, we retrospectively reviewed all patients with laboratory isolates of Shewanella over an 8-y period to assess risk factors, clinical manifestations and outcome. Twenty-nine patients were identified. Shewanella was most commonly isolated from intra-abdominal specimens (48.2%), followed by skin and soft tissue specimens (27.6%), blood (13.8%) and sputum (10.3%). Malignancy, hepatobiliary disease and diabetes mellitus were common underlying diseases. The overall 30-day mortality rate was 20.6%. Shewanella was considered a definite causative pathogen in 7 patients, and a recurrent infection occurred in 2 patients. Colonization of the biliary tract was common. Among co-isolated pathogens, the enteric flora was most represented. All isolates were susceptible to ceftazidime and aminoglycosides, but 1 isolate was resistant to imipenem. In conclusion, Shewanella may become a colonizing bacterium, subsequently causing invasive diseases in patients with an underlying disease. &#169; 2010 Informa Healthcare.</description.abstract>
<language>eng</language>
<publisher>Informa Healthcare. The Journal&apos;s web site is located at http://www.tandf.co.uk/journals/titles/00365548.asp</publisher>
<relation.ispartof>Scandinavian Journal of Infectious Diseases</relation.ispartof>
<subject.mesh>Adult</subject.mesh>
<subject.mesh>Aged</subject.mesh>
<subject.mesh>Aged, 80 and over</subject.mesh>
<subject.mesh>Anti-Bacterial Agents - pharmacology</subject.mesh>
<subject.mesh>Female</subject.mesh>
<subject.mesh>Gram-Positive Bacterial Infections - epidemiology - microbiology - mortality - physiopathology</subject.mesh>
<subject.mesh>Hong Kong - epidemiology</subject.mesh>
<subject.mesh>Humans</subject.mesh>
<subject.mesh>Male</subject.mesh>
<subject.mesh>Microbial Sensitivity Tests</subject.mesh>
<subject.mesh>Middle Aged</subject.mesh>
<subject.mesh>Prognosis</subject.mesh>
<subject.mesh>Retrospective Studies</subject.mesh>
<subject.mesh>Risk Factors</subject.mesh>
<subject.mesh>Shewanella - classification - drug effects - isolation &amp; purification - pathogenicity</subject.mesh>
<title>Epidemiology and clinical features of Shewanella infection over an eight-year period</title>
<type>Article</type>
<description.nature>Link_to_subscribed_fulltext</description.nature>
<identifier.doi>10.3109/00365548.2010.490562</identifier.doi>
<identifier.pmid>20524786</identifier.pmid>
<identifier.scopus>eid_2-s2.0-77956819449</identifier.scopus>
<identifier.hkuros>178247</identifier.hkuros>
<identifier.hkuros>213670</identifier.hkuros>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-77956819449&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>42</identifier.volume>
<identifier.issue>10</identifier.issue>
<identifier.spage>757</identifier.spage>
<identifier.epage>762</identifier.epage>
<identifier.isi>WOS:000282987100006</identifier.isi>
<publisher.place>United Kingdom</publisher.place>
</item>
Author Affiliations
  1. The University of Hong Kong
  2. Queen Mary Hospital Hong Kong